Oral administration of LSN3353871 to mice expressing human Lp(a) resulted in dose-dependent increases in the circulating levels of LSN3353871 and dose-dependent decreases of up to 78% in the levels of Lp(a), with a median effective dose (ED 50 ) of 14 mg kg 1 twice daily (BID) within five days of dosing
Packaging and ingredient quantity are kept minimal, reflecting the "just right" philosophy
The additional ingredients make them ideal for patients looking to improve their metabolism and support weight loss efforts
Research-grade peptides, including ours, are not FDA-approved and are sold for research purposes only
Wu S, Zhu J, Wu G, Hu Z, Ying P, Bao Z, et al
While keeping the skin pinched, slowly push the plunger on the syringe to push the medication into your subcutaneous tissue